Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "CRM's"


12 mentions found


Goldman Sachs initiates Abbott Labs as buy Goldman said Abbott is well positioned for growth. UBS reiterates Apple as neutral UBS said its checks show iPhone pressure remains in China and the U.S. for Apple. Goldman Sachs reiterates Eli Lilly as neutral Goldman raised its price target on Eli Lilly to $785 per share from $740. Goldman Sachs reiterates Salesforce as buy Goldman said it's sticking with the stock following earnings on Wednesday. Goldman Sachs initiates AstraZeneca, Novartis and Novo Nordisk as buy Goldman initiated several biotech company's on Thursday and says it sees "innovation momentum a key focus."
Persons: Baird, OKTA, Goldman Sachs, Abbott, Goldman, Piper Sandler downgrades Cava, Piper, Eli Lilly, Wells Fargo, Wells, Mizuho, Wedbush, Daiwa, Stifel, it's, Salesforce, CRM's, Redburn, Guggenheim, Generac Organizations: UBS, Apple, Mizuho, PayPal, Bank of America, Gross, Amicus, USM, First, Deutsche Bank, Deutsche, JPMorgan, Nvidia, Technology, Northland, AstraZeneca, Novartis, Novo Nordisk, of America, TAM, Guggenheim Locations: China, Corning, Northland, 4Q24
Elon Musk's Neuralink used monkeys to test its brain chip that can connect to a device. Musk said on X, formerly Twitter, that "no monkeys died as a result of Neuralink's chips." "First our early implants, to minimize risk to health monkeys, we chose terminal moneys (close to death already)," Musk wrote on September 10, misspelling monkeys. Other health effects included paralysis, seizures, loss of coordination and balance, and depression, PCRM wrote in the SEC letter. The average age of the dozen monkeys that died during Neuralink's research was 7.25 years, the group said.
Persons: Elon Musk's Neuralink, Musk, Elon Musk, PCRM, Andy Fell, UC Davis Organizations: SEC, Service, Securities and Exchange Commission, Responsible Medicine, WIRED, University of California, Primate Research Center, YouTube, UC Davis, UC, Neuralink, Care, California National Primate Research Center Locations: Wall, Silicon, Davis, California
Nestle buys majority stake in Brazilian premium chocolate maker
  + stars: | 2023-09-07 | by ( ) www.reuters.com   time to read: +2 min
REUTERS/Arnd Wiegmann/File Photo Acquire Licensing RightsZURICH, Sept 7 (Reuters) - Nestle (NESN.S) is buying a majority stake in Brazilian premium chocolate maker Grupo CRM, the Swiss food group said on Thursday. Grupo CRM operates a direct-to-consumer model, with more than 1,000 chocolate boutiques under the Kopenhagen and Brasil Cacau brands and a strong, growing online presence, Nestle said. The executive has been with the company for 25 years and has built up and significantly expanded Grupo CRM, which currently only operates in Brazil. In June, Brazilian competition regulator Cade approved Nestle's acquisition of Chocolates Garoto more than 20 years after it was first announced. Among the conditions for the approval, the company agreed not to make any acquisitions that account for at least 5% of the Brazilian chocolate market for five years.
Persons: Arnd, Nestle, Valor Economico, Renata Moraes Vichi, Laurent Freixe, Cade, John Revill, Friederike Heine, Janane Organizations: Nestle, REUTERS, Rights, Grupo CRM, Brasil, Advent International, Valor, Grupo, Thomson Locations: Konolfingen, Switzerland, Swiss, Brazil
"This quarter puts Salesforce in a league of its own and isn't being appreciated nearly enough at these prices," Jim says. CRM YTD mountain Salesforce's year-to-date stock performance. That is likely why Salesforce stock traded at a valuation "well below" its peers, Smith argued at the time. For context, here's the full list of Salesforce peers included Starboard's presentation: Club holding Microsoft 's (MSFT) productivity and business processes segment, Adobe, Club holding Oracle (ORCL), Intuit (INTU), ServiceNow, Workday and SAP (SAP). Importantly, that $265 target is strictly the result of applying current average peer valuation to Salesforce's current growth/profit mix.
Persons: Marc Benioff, Jim Cramer, Jim, Salesforce, Jeff Smith —, Smith, Salesforce's, , it's, Jim Cramer's, Patrick T Organizations: , Club, ServiceNow, Adobe, Microsoft, Oracle, Intuit, SAP, CRM, CNBC, Salesforce.com Inc, Global Technology, Fallon, Bloomberg, Getty Locations: That's, TurboTax, Salesforce's, Laguna Beach , California, U.S
July 19 (Reuters) - The head of the U.S. agency responsible for animal welfare has told lawmakers that it did not find any violations of animal research rules at Elon Musk's Neuralink beyond a 2019 incident the brain implant company had already reported. The inspection included visits at Neuralink's two facilities in January 2023, Vilsack wrote, adding that there would be more inspections. Vilsack said in his letter his agency did not include in its inspection citations an "adverse surgical event" at Neuralink that occurred in August 2019. The company proactively reported it and took corrective action, which complied with the policy at the time, Vilsack added. The mistakes weakened the experiments' research value and required the tests to be repeated, leading to more animals being killed.
Persons: Thomas Vilsack, Earl Blumenauer, Vilsack, Musk, Neuralink, Blumenauer, Ryan Merkley, Marisa Taylot, Greg Roumeliotis, Robert Birsel Organizations: U.S, Elon Musk's, Department of Agriculture, Reuters, USDA, Physicians, Responsible Medicine, Neuralink, University of California, UC Davis, Drug Administration, FDA, Department of Transportation, Washington , D.C, Thomson Locations: Neuralink, Davis, Washington ,
There are some new names on both the July leaders and July laggards list since we did this exercise looking at our January to June portfolio performance. META 1M mountain Meta stock performance month-to-date. Meta Platforms (META) remains a top performer in the portfolio to start the second half, rising 7.6% for the first two weeks of July after more than doubling in the first half. To start out the first half of 2023, Nvidia was our top-performing stock in the portfolio with nearly a triple. The analysts warned that FL's high exposure to lower-income consumers could pressure the second half of the year.
Persons: Jim Cramer's, Jim, Meta, Baird, Mary Dillon, Foot, Nikesh Arora, PANW, Eli Lilly, Lilly, Mounjaro that's, Johnson, Jim Cramer, Brendan McDermid Organizations: Jim Cramer's Charitable Trust, Investing, Nasdaq, HAL, Halliburton, Natural Resources, Coterra Energy, Meta, Nvidia, Apple, Alto Networks, Palo Alto Networks, Microsoft, PANW, Palo, Reuters, Nordisk, CNBC, Traders, New York Stock Exchange, & ' $ Locations: North America, FL, PANW, Palo, New York City, U.S
Salesforce (CRM) on Tuesday took another step to deliver profitable growth — a welcome development for investors, like us, which sent its stock price higher. Investors appeared upbeat around the list price increases, which Salesforce said are the first in seven years. "I don't expect it to impact churn much," said Berg, who has a buy rating and $230-per-share price target on Salesforce stock. It's worth noting, large customers will usually negotiate with Salesforce to secure a discount to a product's list price. Previously, a customer who bought 100 licenses at a 20% discount to the old list price would've generated $24,000.
Persons: Salesforce, Needham, Scott Berg, Berg, Mizuho, Marc Benioff's, Benioff, He's, Jim Cramer's, Jim Cramer, Jim, Marc Benioff, Salesforce.com, David Paul Morris Organizations: Service, Industries, Nasdaq, Nvidia, Palo Alto Networks, Devices, CNBC, Salesforce, Mizuho Securities, Bloomberg, Getty Locations: Palo, San Francisco
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCramer after CRM's big beat: What are the activists going to say now? Mad Money host Jim Cramer discusses a strong earnings report and full-year forecast with Salesforce CEO Marc Benioff, who's been besieged by multiple activist investors recently.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCramer's sick and tired of the criticism being lobbed at CRM's Marc BenioffMad Money host Jim Cramer addresses the criticism currently being levied at Salesforce CEO Marc Benioff.
Feb 9 (Reuters) - The U.S. Department of Transportation said on Thursday it is investigating Elon Musk's brain-implant company Neuralink over the potentially illegal movement of hazardous pathogens. The Department of Transportation spokesperson said the agency took PCRM's allegations "very seriously." Reuters reviewed the UC Davis records cited by PCRM in its letter. Neuralink messages and records not shared with UC Davis are not subject to such information requests. A UC Davis spokesperson would only say that the university abides by all biohazard and lab safety regulations.
Reuters reviewed the UC Davis records cited by PCRM in its letter. PCRM obtained the records from UC Davis through public information requests. Neuralink messages and records not shared with UC Davis are not subject to such information requests. A UC Davis spokesperson would only say that the university abides by all biohazard and lab safety regulations. During its partnership with UC Davis, Neuralink grew frustrated with what it regarded as the slow pace of testing on primates, current and former company employees told Reuters, and has since built out extensive in-house animal testing facilities.
Salesforce (CRM) laid out a cost-cutting plan on Wednesday that is a step in the right direction for the banged-up Club holding. I know that Starboard would've liked double that [number of layoffs] because that's how bloated they think that Salesforce became." Salesforce is the latest tech company to slash headcount as business slows down from Covid-fueled growth and recession fears mount. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
Total: 12